LARIMAR THERAPEUTICS INC (LRMR) Stock Cash Flow
NASDAQ:LRMR - Nasdaq - US5171251003 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -80.60M | -36.95M | -35.35M | -50.64M | -42.48M | |||
| Depreciation Amortization | 318.00K | 311.00K | 318.00K | 326.00K | 155.00K | |||
| Change In Working Capital | 5.99M | -2.59M | 1.62M | 2.75M | -2.04M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 3.54M | 5.77M | 5.84M | 5.46M | 2.17M | |||
| OPERATING CASH FLOW | -70.76M | -33.46M | -27.57M | -42.10M | -42.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -515.00K | -164.00K | -100.00K | -333.00K | -62.00K | |||
| Other Investing Activity | -84.87M | 33.52M | -90.86M | 24.50M | 17.15M | |||
| INVESTING CASH FLOW | -85.39M | 33.35M | -90.96M | 24.17M | 17.09M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 161.88M | 30.00K | 75.26M | 19.89M | 75.59M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 18.00M | |||
| FINANCING CASH FLOW | 161.88M | 30.00K | 75.26M | 19.89M | 93.59M | |||
| CHANGE IN CASH | 5.74M | -76.00K | -43.27M | 1.95M | 68.48M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -70.76M | -33.46M | -27.57M | -42.10M | -42.20M | |||
| Capital Expenditure | -515.00K | -164.00K | -100.00K | -333.00K | -62.00K | |||
| FREE CASH FLOW | -71.28M | -33.62M | -27.67M | -42.44M | -42.26M | |||
All data in USD